Q32 Bio Inc. (QTTB) vs Utah Medical Products, Inc. (UTMD)
A side-by-side comparison of Q32 Bio Inc. and Utah Medical Products, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
QTTB
Q32 Bio Inc.
$8.11HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
UTMD
Utah Medical Products, Inc.
$73.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — QTTB vs UTMD
growth of $100 · dividends reinvested · last 9yQTTB -97.5% (-33.7%/yr)UTMD -9.3% (-1.1%/yr)UTMD compounded faster over this window
Log scale — wide-divergence pair
QTTB UTMD
QTTB vs UTMD: by the numbers
- •QTTB is the larger company ($241M vs $235M market cap).
- •QTTB trades at the lower trailing earnings multiple (2.91 vs 22.51 P/E), one valuation lens rather than an overall verdict.
- •QTTB converts more revenue to profit (62.87% vs 29.04% net margin).
- •QTTB grew revenue faster over the past five years (10.22% vs -4.75% CAGR).
- •UTMD pays a dividend (1.67% yield), while QTTB has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | QTTB | UTMD |
|---|---|---|
| P/E ratio | 2.91 | 22.51 |
| PEG ratio | N/A | 6.56 |
| P/S ratio | 4.49 | 6.51 |
| P/B ratio | 2.28 | 1.93 |
| EV / EBITDA | 6.41 | 18.54 |
| FCF yield | N/A | 4.87% |
Profitability
| Metric | QTTB | UTMD |
|---|---|---|
| Gross margin | 99.84% | 54.88% |
| Operating margin | 31.45% | 28.46% |
| Net margin | 62.87% | 29.04% |
| ROE | 31.90% | 8.59% |
| ROIC | 19.43% | 6.83% |
Dividends
| Metric | QTTB | UTMD |
|---|---|---|
| Dividend yield | N/A | 1.67% |
| Payout ratio | N/A | 37.80% |
Growth (annualized)
| Metric | QTTB | UTMD |
|---|---|---|
| Revenue CAGR (5Y) | 10.22% | -4.75% |
| EPS CAGR (5Y) | N/A | 3.36% |
| FCF CAGR (5Y) | N/A | -11.12% |
| Total return CAGR (5Y) | -41.51% | -2.70% |
Frequently asked
- Which has the lower trailing P/E, QTTB or UTMD?
- QTTB has the lower trailing P/E: QTTB trades at 2.91 and UTMD at 22.51. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, QTTB or UTMD?
- Over the past five years, QTTB grew revenue faster — QTTB at a 10.22% CAGR versus UTMD at -4.75%.
- Does QTTB or UTMD pay a bigger dividend?
- UTMD pays a dividend (1.67% yield), while QTTB has no payments in the available dividend history.
- Is QTTB or UTMD more profitable?
- QTTB runs the higher net margin — QTTB at 62.87% versus UTMD at 29.04%.
- How have QTTB and UTMD total returns compared?
- Over the past 5 years, QTTB delivered -41.51% and UTMD delivered -2.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Q32 Bio P/E ratioUtah Medical Products P/E ratioUtah Medical Products dividend yieldQ32 Bio ROEUtah Medical Products ROEQ32 Bio operating marginUtah Medical Products operating marginQ32 Bio revenue growthUtah Medical Products revenue growthQ32 Bio free cash flowUtah Medical Products free cash flow
Q32 Bio & Utah Medical Products appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.